Full Name
Aengus Tran
Job Title
Co-Founder and CEO
Company
Harrison.ai
Speaker Bio
Dr Aengus Tran is the co-founder and Chief Executive Officer of Harrison.ai, the global
healthtech company on a mission to scale healthcare capacity using AI.
Combining his background as a medical doctor with his deep expertise in data science and
AI engineering, Aengus co-founded the company with the mission of raising the standard
of healthcare for millions of patients daily.
Since founding Harrison.ai in 2018, Aengus has led the development of breakthrough AI
solutions designed to assist clinicians in making faster and more accurate diagnoses across
various medical fields, including radiology and pathology. These solutions now support care
for over 7 million patients annually across 15 countries.
Under Aengus’s leadership, Harrison.ai has rapidly grown, securing over US$240 million
in funding to advance the medtech’s AI technology and expansion into key international
markets including EMEA, APAC, the US and the UK.`
Aengus has also overseen the development and launch of Harrison.rad.1, a radiology-
specific vision language model being made accessible to industry partners, healthcare professionals, and regulators around the world to spark collective conversations about the
safe, responsible, and ethical use of AI in healthcare.
Aengus has been recognised among Forbes Asia’s 30 Under 30 and the Daily Telegraph’s
Top 30 Tech Entrepreneurs Under 30, reflecting his impact at the intersection of medicine,
technology and innovation.
healthtech company on a mission to scale healthcare capacity using AI.
Combining his background as a medical doctor with his deep expertise in data science and
AI engineering, Aengus co-founded the company with the mission of raising the standard
of healthcare for millions of patients daily.
Since founding Harrison.ai in 2018, Aengus has led the development of breakthrough AI
solutions designed to assist clinicians in making faster and more accurate diagnoses across
various medical fields, including radiology and pathology. These solutions now support care
for over 7 million patients annually across 15 countries.
Under Aengus’s leadership, Harrison.ai has rapidly grown, securing over US$240 million
in funding to advance the medtech’s AI technology and expansion into key international
markets including EMEA, APAC, the US and the UK.`
Aengus has also overseen the development and launch of Harrison.rad.1, a radiology-
specific vision language model being made accessible to industry partners, healthcare professionals, and regulators around the world to spark collective conversations about the
safe, responsible, and ethical use of AI in healthcare.
Aengus has been recognised among Forbes Asia’s 30 Under 30 and the Daily Telegraph’s
Top 30 Tech Entrepreneurs Under 30, reflecting his impact at the intersection of medicine,
technology and innovation.
